Regulatory Intelligence · Clinical Trials & AI
FDA's Real-Time Clinical Trial Initiative and the Limits of AI-Enabled Regulatory Review
This intelligence brief distinguishes real-time clinical data exchange from AI-supported regulatory decision-making and proposes a stepwise, context-specific approach to validation, oversight, and change control.
Read the intelligence brief →